SARS-CoV-2疫苗接种与神经免疫性疾病:综述
本综述汇总国际队列数据,探讨SARS-CoV-2疫苗接种与神经免疫性疾病的关联。数据提示腺病毒载体疫苗与吉兰-巴雷综合征(GBS)可能存在关联,其他疫苗与GBS或贝尔麻痹的关联未在大队列研究中明确。SARS-CoV-2疫苗接种与GBS及可能的贝尔麻痹的相关风险轻微,不应改变推荐个人接种疫苗的建议。
要点
- 腺病毒载体疫苗与吉兰-巴雷综合征(GBS)可能存在关联。
- 其他SARS-CoV-2疫苗与GBS或贝尔麻痹的关联未在大队列研究中明确。
- 接种与GBS及可能贝尔麻痹的相关风险轻微,不应改变接种建议。
核心结论
- SARS-CoV-2疫苗接种与GBS及可能的贝尔麻痹的相关风险轻微,不应改变推荐个人接种疫苗的建议。
- 对于已有神经免疫性疾病者,也应给予同样的接种建议。
研究设计与样本
- 本综述汇总国际队列数据,涉及数百万接种个体。
主要发现
- 数据提示腺病毒载体疫苗与吉兰-巴雷综合征(GBS)之间可能存在关联。
- 其他SARS-CoV-2疫苗与GBS或贝尔麻痹的关联未在大队列研究中明确证明,但mRNA疫苗接种后贝尔麻痹的罕见发生是关注话题。
- 其他神经系统疾病(如中枢神经系统脱髓鞘病或重症肌无力)与任何类型SARS-CoV-2疫苗的因果关系尚未明确证明,尽管接种可能罕见触发已诊断或易感个体的复发、症状加重或首次表现。
临床怎么用
- 原文结论指出,SARS-CoV-2疫苗接种与GBS及可能的贝尔麻痹的相关风险轻微,不应改变推荐个人接种疫苗的建议。
- 对于已有神经免疫性疾病者,也应给予同样的接种建议。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The temporal association between the occurrence of neurological diseases, many autoimmune diseases, and vaccination against SARS-CoV-2 has been topically interesting and remains hotly debated both in the medical literature and the clinic. Given the very low incidences of these events both naturally occurring and in relation to vaccination, it is challenging to determine with certainty whether there is any causative association and most certainly what the pathophysiology of that causation could be. OBSERVATIONS: Data from international cohorts including millions of vaccinated individuals suggest that there is a probable association between the adenovirus-vectored vaccines and Guillain-Barré syndrome (GBS). Further associations between other SARS-CoV-2 vaccines and GBS or Bell palsy have not been clearly demonstrated in large cohort studies, but the possible rare occurrence of Bell palsy following messenger RNA vaccination is a topic of interest. It is also yet to be clearly demonstrated that any other neurological diseases, such as central nervous system demyelinating disease or myasthenia gravis, have any causative association with vaccination against SARS-CoV-2 using any vaccine type, although it is possible that vaccination may rarely trigger a relapse or worsen symptoms or first presentation in already-diagnosed or susceptible individuals. CONCLUSIONS AND RELEVANCE: The associated risk between SARS-CoV-2 vaccination and GBS, and possibly Bell palsy, is slight, and this should not change the recommendation for individuals to be vaccinated. The same advice should be given to those with preexisting neurological autoimmune disease.
引用
- Willison AG, Pawlitzki M, Lunn MP, et al. SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review. JAMA Neurol. 2024. PMID: 38227318. doi:10.1001/jamaneurol.2023.5208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。